AU2003300815A1 - Protein modification and maintenance molecules - Google Patents

Protein modification and maintenance molecules

Info

Publication number
AU2003300815A1
AU2003300815A1 AU2003300815A AU2003300815A AU2003300815A1 AU 2003300815 A1 AU2003300815 A1 AU 2003300815A1 AU 2003300815 A AU2003300815 A AU 2003300815A AU 2003300815 A AU2003300815 A AU 2003300815A AU 2003300815 A1 AU2003300815 A1 AU 2003300815A1
Authority
AU
Australia
Prior art keywords
protein modification
maintenance molecules
molecules
maintenance
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003300815A
Other versions
AU2003300815A8 (en
Inventor
Shanya D. Becha
Umesh G. Bhatia
Julie J. Blake
John D. Burrill
Narinder K. Chawla
Jing Gao
April J. A. Hafalia
Anne Ho
Pei Jin
Amy E. Kable
Reena Khare
Sally Lee
Soo Yeun Lee
Joseph P. Marquis
Patricia M. Mason
Jayalaxmi Ramkumar
Thomas W. Richardson
Anita Swarnakar
Uyen K. Tran
Wenjin Zheng
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Corp filed Critical Incyte Corp
Publication of AU2003300815A8 publication Critical patent/AU2003300815A8/en
Publication of AU2003300815A1 publication Critical patent/AU2003300815A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2003300815A 2002-12-05 2003-12-03 Protein modification and maintenance molecules Abandoned AU2003300815A1 (en)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US43163902P 2002-12-05 2002-12-05
US60/431,639 2002-12-05
US43431502P 2002-12-17 2002-12-17
US60/434,315 2002-12-17
US44244203P 2003-01-24 2003-01-24
US60/442,442 2003-01-24
US44414103P 2003-01-30 2003-01-30
US60/444,141 2003-01-30
US44949103P 2003-02-21 2003-02-21
US60/449,491 2003-02-21
PCT/US2003/038573 WO2004053068A2 (en) 2002-12-05 2003-12-03 Protein modification and maintenance molecules

Publications (2)

Publication Number Publication Date
AU2003300815A8 AU2003300815A8 (en) 2004-06-30
AU2003300815A1 true AU2003300815A1 (en) 2004-06-30

Family

ID=32512689

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003300815A Abandoned AU2003300815A1 (en) 2002-12-05 2003-12-03 Protein modification and maintenance molecules

Country Status (2)

Country Link
AU (1) AU2003300815A1 (en)
WO (1) WO2004053068A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005090569A1 (en) * 2004-03-24 2005-09-29 The Council Of The Queensland Institute Of Medical Research Cancer and testis vsm1 and vsm2 nucleic acids, proteins and uses thereof
WO2006063462A1 (en) 2004-12-13 2006-06-22 Alethia Biotherapeutics Inc. Polynucleotides and polypeptide sequences involved in the process of bone remodeling
EP2035574A1 (en) * 2006-06-17 2009-03-18 Bayer HealthCare AG Use of n-acylaminoacylpeptide hydrolase (apeh) as a therapeutic or diagnostic target
JP2010507387A (en) 2006-10-25 2010-03-11 クアーク・ファーマスーティカルス、インコーポレイテッド Novel siRNA and method of using the same
AU2017281039A1 (en) 2016-06-20 2019-01-24 Healthtell Inc. Methods for differential diagnosis of autoimmune diseases
JP2019526786A (en) 2016-06-20 2019-09-19 ヘルステル・インコーポレイテッドＨｅａｌｔｈｔｅｌｌ Ｉｎｃ． Methods for diagnosis and treatment of autoimmune diseases
AU2017359450A1 (en) 2016-11-09 2019-05-30 HealthTell, Inc. Coatings with tunable amine density
WO2018089858A1 (en) 2016-11-11 2018-05-17 Healthtell Inc. Methods for identifying candidate biomarkers
AU2018289396A1 (en) * 2017-06-19 2020-02-06 Healthtell Inc. Immunosignatures for differential diagnosis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001060860A2 (en) * 2000-02-17 2001-08-23 Millennium Predictive Medicine, Inc. Genes differentially expressed in human prostate cancer and their use
WO2003009814A2 (en) * 2001-07-25 2003-02-06 Millennium Pharmaceuticals, Inc. Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer

Also Published As

Publication number Publication date
WO2004053068A2 (en) 2004-06-24
AU2003300815A8 (en) 2004-06-30
WO2004053068A3 (en) 2005-04-21

Similar Documents

Publication Publication Date Title
AU2002227280A1 (en) Protein modification and maintenance molecules
AU2002950303A0 (en) Improvements in assembly and disassembly
AU2002258388A1 (en) Narc8 programmed cell-death-associated molecules and uses thereof
AU2002318356A1 (en) Protein modification and maintenance molecules
AU2001270271A1 (en) Protein modification and maintenance molecules
AU2003300815A1 (en) Protein modification and maintenance molecules
AU2003205353A1 (en) Protein modification and maintenance molecules
AU2003268023A1 (en) Protein modification and maintenance molecules
AU2002253883A1 (en) Protein modification and maintenance molecules
EP1572168A3 (en) Anti-infarction molecules
AUPS187002A0 (en) Condition-specific molecules and uses therefor
AU2003239871A1 (en) Protein modification and maintenance molecules
AU2002343515A1 (en) Protein modification and maintenance molecules
AU2003231981A1 (en) Protein modification and maintenance molecules
AU2002953223A0 (en) Novel therapeutic molecules and uses thereof
AU2003235096A1 (en) Novel protein and dna thereof
AU2002336529A1 (en) Protein modification and maintenance molecules
AU2002258724A1 (en) Protein modification and maintenance molecules
AU2003236374A1 (en) Atopic dermatitis-inducing proteins
AU2003298589A1 (en) Protein modification and maintenance molecules
AU2003279829A1 (en) Protein modification and maintenance molecules
AU2003280992A1 (en) Novel proteins and use thereof
AU2003219732A1 (en) Oligomeric molecules and uses thereof
AU2003292721A1 (en) Novel protein and its gene
AU2003262080A1 (en) Novel protein and dna thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase